ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development

Cancer Cell

Volumn 26, Issue 3, 2014, Pages 331-343

  Nakagawa, Hayato ^a,e   Umemura, Atsushi ^a   Taniguchi, Koji ^a   Font Burgada, Joan ^a   Dhar, Debanjan ^a   Ogata, Hisanobu ^a,f   Zhong, Zhenyu ^a   Valasek, MarkA ^b   Seki, Ekihiro ^c   Hidalgo, Juan ^d   Koike, Kazuhiko ^e   Kaufman, RandalJ ^g   Karin, Michael ^a,b  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSITY OF TOKYO   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; TUMOR NECROSIS FACTOR RECEPTOR 1; UROKINASE; HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; LIPID DIET; LIPOGENESIS; LIPOTOXICITY; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; MACROPHAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; CELL CULTURE; EXPERIMENTAL LIVER NEOPLASM; FATTY LIVER; GENETICS; METABOLISM; OVERNUTRITION; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR VOLUME;

MUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DIET, HIGH-FAT; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; HEAT-SHOCK PROTEINS; LIPOGENESIS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; OVERNUTRITION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TUMOR BURDEN; TUMOR NECROSIS FACTOR-ALPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84908665169     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2014.07.001     Document Type: Article

References (38)

1. Anderson E.J., Lustig M.E., Boyle K.E., Woodlief T.L., Kane D.A., Lin C.T., Price J.W., Kang L., Rabinovitch P.S., Szeto H.H., et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009, 119:573-581.
2. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin. Liver Dis. 2001, 21:3-16.
3. Caldwell S., Ikura Y., Dias D., Isomoto K., Yabu A., Moskaluk C., Pramoonjago P., Simmons W., Scruggs H., Rosenbaum N., et al. Hepatocellular ballooning in NASH. J. Hepatol. 2010, 53:719-723.
4. Calle E.E., Teras L.R., Thun M.J. Obesity and mortality. N. Engl. J. Med. 2005, 353:2197-2199.
5. Chen C.L., Yang H.I., Yang W.S., Liu C.J., Chen P.J., You S.L., Wang L.Y., Sun C.A., Lu S.N., Chen D.S., Chen C.J. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008, 135:111-121.
6. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
7. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
8. DeZwaan-McCabe D., Riordan J.D., Arensdorf A.M., Icardi M.S., Dupuy A.J., Rutkowski D.T. The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis. PLoS Genet. 2013, 9:e1003937.
9. El-Serag H.B. Hepatocellular carcinoma. N. Engl. J. Med. 2011, 365:1118-1127.
10. Farrell G.C., van Rooyen D., Gan L., Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012, 6:149-171.
11. Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
12. Haybaeck J., Zeller N., Wolf M.J., Weber A., Wagner U., Kurrer M.O., Bremer J., Iezzi G., Graf R., Clavien P.A., et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 2009, 16:295-308.
13. He G., Dhar D., Nakagawa H., Font-Burgada J., Ogata H., Jiang Y., Shalapour S., Seki E., Yost S.E., Jepsen K., et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 2013, 155:384-396.
14. Holzer R.G., Park E.J., Li N., Tran H., Chen M., Choi C., Solinas G., Karin M. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 2011, 147:173-184.
15. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
16. Inami Y., Waguri S., Sakamoto A., Kouno T., Nakada K., Hino O., Watanabe S., Ando J., Iwadate M., Yamamoto M., et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 2011, 193:275-284.
17. Kammoun H.L., Chabanon H., Hainault I., Luquet S., Magnan C., Koike T., Ferré P., Foufelle F. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 2009, 119:1201-1215.
18. Lee A.H., Scapa E.F., Cohen D.E., Glimcher L.H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008, 320:1492-1496.
19. Lee J.H., Budanov A.V., Talukdar S., Park E.J., Park H.L., Park H.W., Bandyopadhyay G., Li N., Aghajan M., Jang I., et al. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metab. 2012, 16:311-321.
20. Maeda S., Kamata H., Luo J.L., Leffert H., Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121:977-990.
21. Malhi H., Kaufman R.J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 2011, 54:795-809.
22. Ota T., Gayet C., Ginsberg H.N. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Invest. 2008, 118:316-332.
23. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Görgün C.Z., Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313:1137-1140.
24. Park E.J., Lee J.H., Yu G.Y., He G., Ali S.R., Holzer R.G., Osterreicher C.H., Takahashi H., Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140:197-208.
25. Puri P., Mirshahi F., Cheung O., Natarajan R., Maher J.W., Kellum J.M., Sanyal A.J. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008, 134:568-576.
26. Qiu W., Zhang J., Dekker M.J., Wang H., Huang J., Brumell J.H., Adeli K. Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B. Hepatology 2011, 53:1515-1525.
27. Rutkowski D.T., Wu J., Back S.H., Callaghan M.U., Ferris S.P., Iqbal J., Clark R., Miao H., Hassler J.R., Fornek J., et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev. Cell 2008, 15:829-840.
28. Sakurai T., He G., Matsuzawa A., Yu G.Y., Maeda S., Hardiman G., Karin M. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008, 14:156-165.
29. Salomao M., Remotti H., Vaughan R., Siegel A.B., Lefkowitch J.H., Moreira R.K. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Hum. Pathol. 2012, 43:737-746.
30. Sandgren E.P., Palmiter R.D., Heckel J.L., Daugherty C.C., Brinster R.L., Degen J.L. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991, 66:245-256.
31. Schramm C., Schneider A., Marx A., Lohse A.W. Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH). Z. Gastroenterol. 2008, 46:1369-1371.
32. So J.S., Hur K.Y., Tarrio M., Ruda V., Frank-Kamenetsky M., Fitzgerald K., Koteliansky V., Lichtman A.H., Iwawaki T., Glimcher L.H., Lee A.H. Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. Cell Metab. 2012, 16:487-499.
33. Soon R.K., Yan J.S., Grenert J.P., Maher J.J. Stress signaling in the methionine-choline-deficient model of murine fatty liver disease. Gastroenterology 2010, 139:1730-1739.e1.
34. Tilg H., Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010, 52:1836-1846.
35. Toffanin S., Friedman S.L., Llovet J.M. Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link. Cancer Cell 2010, 17:115-117.
36. Wang G., Yang Z.Q., Zhang K. Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res 2010, 2:65-74.
37. Weglarz T.C., Degen J.L., Sandgren E.P. Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am. J. Pathol. 2000, 157:1963-1974.
38. Xu C., Bailly-Maitre B., Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 2005, 115:2656-2664.